<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="695">
  <stage>Registered</stage>
  <submitdate>13/09/2005</submitdate>
  <approvaldate>21/09/2005</approvaldate>
  <actrnumber>ACTRN12605000455662</actrnumber>
  <trial_identification>
    <studytitle>MSBase- An international Registry dedicated to evaluating outcomes data in Multiple Sclerosis</studytitle>
    <scientifictitle>MSBase- An international Registry dedicated to evaluating outcomes data in Multiple Sclerosis</scientifictitle>
    <utrn />
    <trialacronym>MSBase</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Multiple Sclerosis</healthcondition>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Multiple sclerosis</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The MSBase study is an ongoing, observational registry tracking the natural history of Multiple Sclerosis in the long term. In collaboration with participating neurologists the MSBase Registry will establish a unique international database for tracking  and evaluating outcomes data in MS.</interventions>
    <comparator />
    <control />
    <interventioncode>Other interventions</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>EDSS score</outcome>
      <timepoint />
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Kurtzke Functional Score</outcome>
      <timepoint />
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Relapse rate</outcome>
      <timepoint />
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Treatment and/or hospital admission for relapse</outcome>
      <timepoint />
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Commencement or cessation of disease modifying drugs</outcome>
      <timepoint />
    </primaryOutcome>
    <primaryOutcome>
      <outcome>MRI findings</outcome>
      <timepoint />
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Time to second relapse (time to Clinically definite MS).</outcome>
      <timepoint />
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>All patients with Clinically Isolated Syndromes/ First Demyelinating Events  suggestive of MS and all patients with Multiple Sclerosis are eligible provided the neurologist maintains the standardised minimum dataset including annual assessment of the patients Expanded Disability Status Score.</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>Not stated</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>No exclusion criteria</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Natural history</purposeobs>
    <duration>Longitudinal</duration>
    <selection>Defined population</selection>
    <timing>Both</timing>
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/06/2003</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>10000</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia,Outside</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Charities/Societies/Foundations</primarysponsortype>
    <primarysponsorname>MSBase Foundation Ltd</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Other</fundingtype>
      <fundingname>Grants from private and public agencies</fundingname>
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>Nil</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The MSBase Registry is a longitudinal, strictly observational Multiple Sclerosis database open to all practicing Neurologists worldwide. In collaboration with participating Neurologists, the MSBase Registry has established a unique, web-based platform dedicated to sharing, tracking and evaluating outcomes data in Multiple Sclerosis (MS). In particular, MSBase aims to advance multi-centre, multi-national epidemiological and outcomes research by providing a freely accessible resource to compile, combine, compare and analyse large datasets.
Participating Neurologists submit anonymized core clinical information using the freely available iMed software as a standardized data collection instrument. The core data to be collected is termed the minimum dataset, comprising key parameters relating to diagnosis, serial neurological examinations (Kurtzke Functional Score and Expanded Disability Status Score, EDSS), relapse information and treatment exposures. All aspects of patient management are entirely at the discretion of the managing neurologist and his or her patient.
Anonymized aggregate data generated from the MSBase Registry will be reported to participating Neurologists on a regular basis. Important findings will be shared with the general neurology community at scientific meetings and through journal publications.
The MSBase Scientific Advisory Board (SAB) acts as the custodian of the composite data, while individual datasets at all times remain the property of the participating physician. The MSBase SAB will ensure data integrity and monitor all MSBase activities including core study designs, promotion and implementation, and perform composite data analyses.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Royal Melbourne Hospital</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Box Hill Hospital</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>St Vincent's Hospital</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>John Hunter Hospital</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Mrs Michelle Hoffmann</name>
      <address>MSBase Foundation
Department of Neurology
Royal Melbourne Hospital
Grattan St
Parkville VIC 3050</address>
      <phone>+61 3 93428070</phone>
      <fax>+61 3 93428070</fax>
      <email>msbase@mh.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Mrs Michelle Hoffmann</name>
      <address>MSBase Foundation
Department of Neurology
Royal Melbourne Hospital
Grattan St
Parkville VIC 3050</address>
      <phone>+61 3 93428070</phone>
      <fax>+61 3 93428070</fax>
      <email>msbase@mh.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>